became adipsic following a subarachnoid hemorrhage and subsequently had two episodes of life-threatening hypernatremia. Investigations demonstrated that he had defective osmoregulated thirst and AVP release, but normal AVP responses to hypotension and nausea. There is also evidence that he had intact baroregulated thirst. We discuss the results of our investigations in the context of current models of hypothalamic-neurohypophysial function.
In health, plasma osmolality is maintained within strict limits by variation in both fluid intake and output. With rising plasma osmolality arginine va¬ sopressin (AVP, antidiuretic hormone) is released from the posterior pituitary under the influence of a putative hypothalamic osmoreceptor (1, 2) . This causes increased absorption of water from the renal collecting system and high urinary osmolality, con¬ serving body water. As plasma osmolality rises, thirst intensity also increases causing increased fluid intake (3, 4) . Osmotically stimulated thirst is also mediated via a hypothalamic centre which is intimately related, if not identical to the osmore¬ ceptor (1, 5) . Non-osmotic stimuli to AVP release include hypotension, hypovolemia, hypoglycemia, and nausea and vomiting (6, 7) . Weiss et al. (8) have demonstrated that hypovolemia also stimulates thirst, but little is known about the pathophysiology of this response. Rare patients manifest lesions in¬ volving the osmoreceptor (9) (10) (11) (12) 
The maximum urinary osmolality recorded was 1249 mOsm/kg corresponding to a serum osmolality of 329 mOsm/kg and a serum creatinine of 100 nmol/1.
All studies were carried out on separate days, after an overnight fast with free access to water. Plasma AVP was measured using a sensitive and specific radioimmunoasay (intra-assay coefficient of variation 9.7% at 2 pmol/1, 13 
Results
The response of plasma AVP to hypertonic saline infusion, oral water load, and 5% dextrose load is shown in Fig. 1 . The maximum plasma AVP (0.7 pmol/1) occured at a plasma osmolality of 305 mOsm/kg, prior to the beginning of the 5% saline infusion. During this infusion, the plasma osmolal¬ ity rose to 328 mOsm/kg at which time the plasma AVP was 0.6 pmol/1 (normal > 12 pmol/1, 4,14) . The hematocrit fell from 42.5 to 39.3%. At no point during the infusion did the patient complain of thirst and in the 2 h after the infusion, when the patient was given free access to fluids, only 40 (Fig. 1) . DeRubertis et al. (9) have postulated that the ability of these pa¬ tients to produce concentrated urine is due to intact volume regulation of AVP release. Our results would support the hypothesis that a high renal sen¬ sitivity to AVP combined with intact volume-regu¬ lated AVP release leads to the production of ap¬ propriately concentrated urine at high plasma osmolalities.
Reports of a patient with an isolated defect in osmoregulated thirst (5) 
